Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-12-30 5:27 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,518,039 10% | 3,520 (+0.23%) | View |
| 2020-12-28 5:13 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,514,519 9.99% | 1,319,193 (+675.38%) | View |
| 2020-12-04 5:12 pm Sale | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 73,650 5.1% | -103,200 (-58.35%) | View |
| 2020-11-20 4:39 pm Unchanged | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 176,850 12.4% | 0 (Unchanged) | View |
| 2020-11-09 12:42 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | Logos Global Management LP | 224,071 15.7% | 224,071 (New Position) | View |
| 2020-10-13 9:20 pm Purchase | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 176,850 14.1% | 176,850 (New Position) | View |
| 2020-10-05 5:26 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 195,326 15.6% | 195,326 (New Position) | View |
| 2020-08-18 4:35 pm Unchanged | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 16.4% | 0 (Unchanged) | View |
| 2020-02-25 5:04 pm Sale | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 19.8% | -1,292,408 (-28.88%) | View |
| 2020-02-13 7:51 pm Sale | 13G | NOVUS THERAPEUTICS INC NVUS | LIFESCI INDEX PARTNERS LLC | 125,000 0.9% | -1,026,088 (-89.14%) | View |
| 2020-02-13 09:52 am Sale | 13G | NOVUS THERAPEUTICS INC NVUS | 683 Capital Management LLC | 946,204 7% | -246,613 (-20.67%) | View |
| 2019-07-26 2:48 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | 683 Capital Management LLC | 1,192,817 8.8% | 1,192,817 (New Position) | View |
| 2019-06-05 2:59 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | ARMISTICE CAPITAL LLC | 657,647 4.99% | 657,647 (New Position) | View |
| 2019-05-10 4:24 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,336,556 9.99% | 1,336,556 (New Position) | View |